Total Funding
63
65
Total FundingPost-IPO Equity raised
Growth Score
-9 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
28869
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.
R. Scott Struthers: Founder & Chief Executive Officer
Yun-Fei Zhu: Co-Founder & Vice President, Chemistry
About the Company
Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to
achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.
